| Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7 JY Tan, KW Vance, MA Varela, T Sirey, LM Watson, HJ Curtis, ... Nature structural & molecular biology 21 (11), 955-961, 2014 | 94 | 2014 |
| Dominant mutations in GRM1 cause spinocerebellar ataxia type 44 LM Watson, E Bamber, RP Schnekenberg, J Williams, C Bettencourt, ... The American Journal of Human Genetics 101 (3), 451-458, 2017 | 89 | 2017 |
| A simplified method for generating Purkinje cells from human-induced pluripotent stem cells LM Watson, MMK Wong, J Vowles, SA Cowley, EBE Becker The Cerebellum 17 (4), 419-427, 2018 | 55 | 2018 |
| Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation MMK Wong, SD Hoekstra, J Vowles, LM Watson, G Fuller, AH Németh, ... Acta neuropathologica communications 6 (1), 1-14, 2018 | 47 | 2018 |
| Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia LM Watson, MMK Wong, EBE Becker Open Biology 5 (7), 150056, 2015 | 41 | 2015 |
| Allele-specific silencing of mutant Ataxin-7 in SCA7 patient-derived fibroblasts J Scholefield, L Watson, D Smith, J Greenberg, MJA Wood European Journal of Human Genetics 22 (12), 1369-1375, 2014 | 33 | 2014 |
| Inherited polyglutamine spinocerebellar ataxias in South Africa DC Smith, A Bryer, LM Watson, LJ Greenberg SAMJ: South African Medical Journal 102 (8), 683-686, 2012 | 27 | 2012 |
| RNA therapy for polyglutamine neurodegenerative diseases LM Watson, MJA Wood Expert reviews in molecular medicine 14, 2012 | 15 | 2012 |
| Recent advances in modelling of cerebellar ataxia using induced pluripotent stem cells MMK Wong, LM Watson, EBE Becker Journal of Neurology and Neuromedicine 2 (7), 11-15, 2017 | 12 | 2017 |
| Spinocerebellar ataxia type 7 in South Africa: epidemiology, pathogenesis and therapy: the new millennium LM Watson, DC Smith, J Scholefield, R Ballo, S Kidson, LJ Greenberg, ... South African Medical Journal 106 (Supplement 1), 107-109, 2016 | 10 | 2016 |
| Polyglutamine disease: from pathogenesis to therapy LM Watson, J Scholefield, LJ Greenberg, MJA Wood SAMJ: South African Medical Journal 102 (6), 481-484, 2012 | 10* | 2012 |
| Molecular and electrophysiological features of spinocerebellar ataxia type seven in induced pluripotent stem cells RJ Burman, LM Watson, DC Smith, JV Raimondo, R Ballo, J Scholefield, ... PloS one 16 (2), e0247434, 2021 | 6 | 2021 |
| Corrigendum: Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7. JY Tan, KW Vance, MA Varela, T Sirey, LM Watson, HJ Curtis, ... Nature structural & molecular biology 22 (3), 272, 2015 | 5 | 2015 |
| Novel Cell Models for the Study of Spinocerebellar Ataxia Type 7 Pathogenesis and Therapy in a South African Patient Cohort LM Watson University of Cape Town, 2012 | 2 | 2012 |
| Transcriptional and electrophysiological aberrations in an induced pluripotent stem cell-derived model of spinocerebellar ataxia type 7 LM Watson, DC Smith, JV Raimondo, RJ Burman, R Ballo, J Scholefield, ... bioRxiv, 288480, 2018 | | 2018 |
| RNA Therapy for Polyglutamine Neurodegenerative Diseases DC Smith, LM Watson, JLJ Greenberg, MJA Wood, J Scholefield eLS, 2013 | | 2013 |
| Polyglutamine disease: from pathogenesis to therapy: forum-analysis J Scholefield, LJ Greenberg, MJA Wood, LM Watson African Journal of Health Professions Education 102 (6), 481-484, 2012 | | 2012 |
| Elucidating the molecular basis of a novel autosomal dominant fibrotic syndrome L Watson University of Cape Town, 2009 | | 2009 |
Leslie, Jacquie GreenbergProfessor in Human GeneticsVerified email at uct.ac.za
